Home › Funds › GROUPAMA ASSET MANAGMENT › REGN

GROUPAMA ASSET MANAGMENT position in REGN

REGENERON PHARMACEUTICALS · Health Care

GROUPAMA ASSET MANAGMENT reported holding 77,940 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$49.1M, representing 0.65% of its reported portfolio and ranking #39 among its reported holdings. GROUPAMA ASSET MANAGMENT has disclosed REGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)77.94K sh
Reported value held$49.13M
Portfolio Weight0.65%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GROUPAMA ASSET MANAGMENT's REGN position evolved

GROUPAMA ASSET MANAGMENT first disclosed a stake in REGN in Q4 2023 at 67,371 shares (US$59.2M). The position peaked in Q2 2024 at 66,629 shares, worth US$70.0M. Across 11 filings, GROUPAMA ASSET MANAGMENT increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 77,940 shares valued at US$49.1M — an increase of 6,838 shares quarter over quarter.. Notable position changes include a 25% trim in Q1 2024 (shares rose 9% over the following quarter), a 33% increase in Q2 2024 (shares were roughly flat over the following quarter), a 25% trim in Q2 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 67.37K $59.19M New
Q1 2024 50.21K $64.52M Reduce
Q2 2024 66.63K $70.03M Add
Q3 2024 71.28K $60.16M Add
Q4 2024 80.34K $56.45M Add
Q1 2025 90.61K $57.75M Add
Q2 2025 67.87K $35.36M Reduce
Q3 2025 62.70K $35.25M Reduce
Q4 2025 71.18K $54.94M Add
Q1 2026 71.10K $54.94M Hold
Q2 2026 77.94K $49.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has GROUPAMA ASSET MANAGMENT held REGN?

GROUPAMA ASSET MANAGMENT has disclosed REGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is GROUPAMA ASSET MANAGMENT's current position in REGN?

As of Q2 2026, GROUPAMA ASSET MANAGMENT holds 77.94K shares of REGN (REGENERON PHARMACEUTICALS), valued at $49.13M, representing 0.65% of its reported portfolio and ranking #39.

Has GROUPAMA ASSET MANAGMENT been buying or selling REGN?

In the latest 13F filing (Q2 2026), GROUPAMA ASSET MANAGMENT increased its position in REGN. The position peaked in Q2 2024 at 66.63K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.